Replies to post #244362 on Biotech Values

[DewDiligence]

Regardless of how you slice and dice it, RVNC should be able to market longer duration vs Botox and other toxins.

Agreed. I just posted on this topic in #msg-170330358.

(Note: My page references to the FDA label for Botox Cosmetic refer to the 2009 label for the approval in glabellar lines; in the more recent Botox Cosmetic label you cited, the information I cited may appear on a different page.)